A New Class of Small Molecule Inhibitor of BMP Signaling

• Caroline E. Sanvitale,

  Affiliation Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom

  ⨯
• Georgina Kerr,

  Affiliation Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom

  ⨯
• Apirat Chaikuad,

  Affiliation Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom

  ⨯
• Marie-Christine Ramel,

  Affiliation Laboratory of Developmental Signalling, Cancer Research UK London Research Institute, London, United Kingdom

  ⨯
• Agustin H. Mohedas,

  Affiliation Department of Medicine Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Sabine Reichert,

  Affiliation Laboratory of Developmental Signalling, Cancer Research UK London Research Institute, London, United Kingdom

  ⨯
• You Wang,

  Affiliation Laboratory for Drug Discovery in Neurodegeneration, Brigham and Women’s Hospital and Harvard Medical School, Cambridge, Massachusetts, United States of America

  ⨯
• James T. Triffitt,

  Affiliation Botnar Research Centre, University of Oxford, Oxford, United Kingdom

  ⨯
• Gregory D. Cuny,

  Current address: Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, Texas, United States of America

  Affiliation Laboratory for Drug Discovery in Neurodegeneration, Brigham and Women’s Hospital and Harvard Medical School, Cambridge, Massachusetts, United States of America

  ⨯
• Paul B. Yu,

  Affiliation Department of Medicine Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Caroline S. Hill,

  Affiliation Laboratory of Developmental Signalling, Cancer Research UK London Research Institute, London, United Kingdom

  ⨯
• Alex N. Bullock

  * E-mail: alex.bullock@sgc.ox.ac.uk

  Affiliation Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom

  ⨯